IMATINIB AND STATINS

Imatinib increased the maximum serum levels of simvastatin 2-fold and the AUC 3.5-fold in one study.
These rises increase the risk of simvastatin toxicity (most notably myopathy and rhabdomyolysis), for which reason the simvastatin dosage should be reduced appropriately. Patients should be counselled regarding myopathy (e.g. report any unexplained muscle pain, tenderness or weakness).
(58)
This site is intended for general information only. The information provided on this site does not constitute medical advice and should not be relied upon. You should not act or refrain from acting on any legal or medical matter based on the content of this site.
© 2006-2025 medpill.info Last Updated On: 06/10/2025 (0)
×
Wait 20 seconds...!!!